Imperial College Academic Health Science Centre (AHSC) has been re-designated an AHSC by the National Institute of Health Research and NHS England/Improvement for a further five years.
One of only eight centres in the UK to receive the designation, it recognises Imperial College AHSC, a University-NHS partnership, as a centre of excellence in health research, education and patient care.
Imperial College AHSC is partnership between the Trust, Imperial College London, Imperial College Healthcare NHS Trust, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR). Our Trust, alongside the other partners, will contribute expert clinical and research insight to key scientific fields that make up the centre’s six areas of focus for the next five years: cardiovascular disease, respiratory disease, brain disease, cancer, infection and antimicrobial disease, and metabolic disease.
Imperial College AHSC brings together these five world-leading, West London-based institutions around a common research, education and service mission. Since first receiving the designation in 2007, it has united world-leading clinicians, researchers and educators to advance a better understanding of, and new scientific and medical breakthroughs in, some of the world’s toughest and urgent health challenges.
The AHSC will combine scientific and clinical intelligence with NHS data to generate new insights into disease patterns – including disease prevention and early detection – and to evaluate and trial new treatments to improve the healthcare of millions of patients.
As a specialist heart and lung centre, the Trust will continue to play a significant role in the partnership by developing new approaches to clinical care and research for a spectrum of cardiac and respiratory conditions.